Correlation Between RenovoRx and Immunoprecise Antibodies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Immunoprecise Antibodies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Immunoprecise Antibodies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Immunoprecise Antibodies, you can compare the effects of market volatilities on RenovoRx and Immunoprecise Antibodies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Immunoprecise Antibodies. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Immunoprecise Antibodies.

Diversification Opportunities for RenovoRx and Immunoprecise Antibodies

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between RenovoRx and Immunoprecise is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Immunoprecise Antibodies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunoprecise Antibodies and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Immunoprecise Antibodies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunoprecise Antibodies has no effect on the direction of RenovoRx i.e., RenovoRx and Immunoprecise Antibodies go up and down completely randomly.

Pair Corralation between RenovoRx and Immunoprecise Antibodies

Given the investment horizon of 90 days RenovoRx is expected to generate 0.67 times more return on investment than Immunoprecise Antibodies. However, RenovoRx is 1.49 times less risky than Immunoprecise Antibodies. It trades about 0.37 of its potential returns per unit of risk. Immunoprecise Antibodies is currently generating about -0.21 per unit of risk. If you would invest  98.00  in RenovoRx on August 29, 2024 and sell it today you would earn a total of  38.00  from holding RenovoRx or generate 38.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

RenovoRx  vs.  Immunoprecise Antibodies

 Performance 
       Timeline  
RenovoRx 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in RenovoRx are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, RenovoRx unveiled solid returns over the last few months and may actually be approaching a breakup point.
Immunoprecise Antibodies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immunoprecise Antibodies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

RenovoRx and Immunoprecise Antibodies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with RenovoRx and Immunoprecise Antibodies

The main advantage of trading using opposite RenovoRx and Immunoprecise Antibodies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Immunoprecise Antibodies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunoprecise Antibodies will offset losses from the drop in Immunoprecise Antibodies' long position.
The idea behind RenovoRx and Immunoprecise Antibodies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges